A Comparison of Recombinant Human Brain Natriuretic Peptide and Dobutamine

NCT01837849 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2013-04-23

No results posted yet for this study

Summary

To compare the therapeutic efficacy of recombinant human brain natriuretic peptide (rhBNP) with dobutamine on acute decompensated heart failure patients with different blood BNP levels

Conditions

  • Acute Decompensated Heart Failure

Sponsors & Collaborators

  • Nantong University

    lead OTHER

Principal Investigators

  • Jianhua Zhu, MD · Affiliated Hospital of Nantong University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-06-30
Completion
2012-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01837849 on ClinicalTrials.gov